Lila Feisee

Array ( [id] => 2996106 [patent_doc_number] => 05358864 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-10-25 [patent_title] => 'Cloning and expression of xylanase genes from fungal origin' [patent_app_type] => 1 [patent_app_number] => 7/842349 [patent_app_country] => US [patent_app_date] => 1992-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 27 [patent_no_of_words] => 18642 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/358/05358864.pdf [firstpage_image] =>[orig_patent_app_number] => 842349 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3417072 [patent_doc_number] => 05434075 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-07-18 [patent_title] => 'Monoclonal antibody to a human MDR1 multidrug resistance gene product, and uses' [patent_app_type] => 1 [patent_app_number] => 7/854881 [patent_app_country] => US [patent_app_date] => 1992-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 4 [patent_no_of_words] => 10916 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/434/05434075.pdf [firstpage_image] =>[orig_patent_app_number] => 854881 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3649002 [patent_doc_number] => 05605831 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-25 [patent_title] => 'Human melanoma cell specific antigens and antibodies' [patent_app_type] => 1 [patent_app_number] => 7/829855 [patent_app_country] => US [patent_app_date] => 1992-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 8 [patent_no_of_words] => 5613 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/605/05605831.pdf [firstpage_image] =>[orig_patent_app_number] => 829855 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3122282 [patent_doc_number] => 05436154 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-07-25 [patent_title] => 'Monoclonal antibodies against human Tumor Necrosis Factor .alpha.' [patent_app_type] => 1 [patent_app_number] => 7/806401 [patent_app_country] => US [patent_app_date] => 1991-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 12936 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/436/05436154.pdf [firstpage_image] =>[orig_patent_app_number] => 806401 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2951978 [patent_doc_number] => 05262523 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-11-16 [patent_title] => 'Antibodies reactive with normal and oncogenic forms of the ras p21 protein' [patent_app_type] => 1 [patent_app_number] => 7/800052 [patent_app_country] => US [patent_app_date] => 1991-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4678 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/262/05262523.pdf [firstpage_image] =>[orig_patent_app_number] => 800052 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2984595 [patent_doc_number] => 05266478 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-11-30 [patent_title] => 'Antibodies which target a neutralization site within the second variable region of human immunodeficiency virus type 1 gp120' [patent_app_type] => 1 [patent_app_number] => 7/797692 [patent_app_country] => US [patent_app_date] => 1991-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5814 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/266/05266478.pdf [firstpage_image] =>[orig_patent_app_number] => 797692 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3078087 [patent_doc_number] => 05321008 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-06-14 [patent_title] => 'Methods and compositions for treatment of diabetes mellitus, hypoglycemia, and other conditions' [patent_app_type] => 1 [patent_app_number] => 7/774411 [patent_app_country] => US [patent_app_date] => 1991-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6551 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/321/05321008.pdf [firstpage_image] =>[orig_patent_app_number] => 774411 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3046863 [patent_doc_number] => 05286852 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-02-15 [patent_title] => 'Antibodies specific towards HIV-1 gp 48' [patent_app_type] => 1 [patent_app_number] => 7/772604 [patent_app_country] => US [patent_app_date] => 1991-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11946 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/286/05286852.pdf [firstpage_image] =>[orig_patent_app_number] => 772604 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3054648 [patent_doc_number] => 05344915 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-09-06 [patent_title] => 'Proteins and the preparation thereof' [patent_app_type] => 1 [patent_app_number] => 7/768443 [patent_app_country] => US [patent_app_date] => 1991-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3061 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/344/05344915.pdf [firstpage_image] =>[orig_patent_app_number] => 768443 [rel_patent_id] =>[rel_patent_doc_number] =>)